Virax Biolabs Group Limit... (VRAX)
NASDAQ: VRAX
· Real-Time Price · USD
0.76
-0.02 (-2.96%)
At close: Aug 19, 2025, 11:55 AM
Virax Biolabs Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Sep 30, 2024 | Mar 31, 2024 | Sep 30, 2023 | Mar 31, 2023 | Sep 30, 2022 | Mar 31, 2022 | Sep 30, 2021 | Mar 31, 2021 | Sep 30, 2020 |
Revenue | 4.95K | 79.92K | 76.5K | 2.8K | 5.76K | -92.86K | n/a | 109.82K | 14K |
Cost of Revenue | 11.43K | 39.85K | 65.98K | 4.28K | 5.64K | 99.94K | n/a | 133.25K | n/a |
Gross Profit | -6.47K | 40.07K | 10.52K | -1.48K | 118.00 | -192.81K | n/a | -23.43K | 14K |
Operating Income | -2.88M | -3.79M | -2.71M | -4.29M | -1.44M | -1.17M | -566.74K | -273.08K | -371.46K |
Interest Income | n/a | n/a | 10.11K | 5.86K | 9.61K | 1.29K | 14.14K | 10.51K | 18.13K |
Pretax Income | -2.89M | -3.82M | -2.91M | -4M | -1.45M | -1.17M | -575.04K | -283.33K | -389.58K |
Net Income | -2.76M | -3.82M | -2.91M | -4.01M | -1.44M | -1.16M | -552.42K | -307.53K | -343.46K |
Selling & General & Admin | 2.15M | 2.29M | 2.31M | 3.99M | 1.34M | 841.29K | 458.64K | 187.92K | 326.96K |
Research & Development | 726.41K | 1.15M | 409.3K | 300.49K | 96.62K | 325.65K | 108.1K | 61.72K | 58.5K |
Other Expenses | n/a | 390.36K | n/a | n/a | n/a | 519.23K | n/a | n/a | n/a |
Operating Expenses | 2.87M | 3.83M | 2.72M | 4.29M | 1.44M | 1.17M | 566.74K | 249.65K | 385.46K |
Interest Expense | 25.59K | 16.76K | 10.11K | 5.86K | 9.61K | 1.29K | 14.14K | 10.51K | 18.13K |
Selling & Marketing Expenses | n/a | 33K | 33K | 25.35K | 51.97K | 9.76K | 4.06K | 15.06K | 42.14K |
Cost & Expenses | 2.88M | 3.87M | 2.78M | 4.29M | 1.45M | 1.17M | 566.74K | 382.9K | 385.46K |
Income Tax Expense | -136.66K | n/a | -4.55K | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.1M | 2.23M | 1.78M | 1.55M | 1.17M | 1.14M | 1.14M | 1.14M | 1.14M |
Shares Outstanding (Diluted) | 3.1M | 2.24M | 1.78M | 1.55M | 1.17M | 1.14M | 1.14M | 1.14M | 1.14M |
EPS (Basic) | -0.89 | -1.71 | -1.64 | -2.58 | -1.24 | -1.02 | -0.49 | -0.27 | -0.3 |
EPS (Diluted) | -0.89 | -1.71 | -1.64 | -2.58 | -1.24 | -1.02 | -0.49 | -0.27 | -0.3 |
EBITDA | -2.77M | -3.72M | -2.69M | 294.07K | -3.6K | -1.19M | 5.84K | 260.00 | 10.00 |
EBIT | -2.88M | -3.81M | -2.71M | -4M | -1.44M | -1.17M | -560.9K | -272.82K | -371.45K |
Depreciation & Amortization | 112.09K | 85.38K | 17.72K | 4.29M | 1.44M | 1.17M | 566.74K | 273.08K | 371.46K |